We recently reported that SMS1 deficiency leads to glucosylceramide (GluCer) accumulation, and this is one of the triggers promoting the development of fatty liver into NASH, and subsequently fibrosis and tumorigenesis (34). Here, SGMS1 is linked to metabolic dysfunction-associated steatohepatitis.